326 related articles for article (PubMed ID: 30338648)
61. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
62. Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.
Hargreaves P; Daoudlarian D; Theron M; Kolb FA; Manchester Young M; Reis B; Tiaden A; Bannert B; Kyburz D; Manigold T
Arthritis Res Ther; 2019 Jul; 21(1):175. PubMed ID: 31319889
[TBL] [Abstract][Full Text] [Related]
63. Lycium barbarum Polysaccharide Ameliorates Sjögren's Syndrome in a Murine Model.
Wang Y; Xiao J; Duan Y; Miao M; Huang B; Chen J; Cheng G; Zhou X; Jin Y; He J; Li Z; So KF
Mol Nutr Food Res; 2021 Jun; 65(11):e2001118. PubMed ID: 33825332
[TBL] [Abstract][Full Text] [Related]
64. Total glucosides of paeony ameliorates TNBS‑induced colitis by modulating differentiation of Th17/Treg cells and the secretion of cytokines.
Lin H; Zhang W; Jiang X; Chen R; Huang X; Huang Z
Mol Med Rep; 2017 Dec; 16(6):8265-8276. PubMed ID: 28944916
[TBL] [Abstract][Full Text] [Related]
65. Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation.
Li B; He S; Liu R; Huang L; Liu G; Wang R; Yang Z; Liu X; Leng Y; Liu D; Ye C; Li Y; Chen Y; Yin H; Fang W
J Ethnopharmacol; 2019 Oct; 243():112121. PubMed ID: 31356966
[TBL] [Abstract][Full Text] [Related]
66. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
[TBL] [Abstract][Full Text] [Related]
67. Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.
Suleman M; Cyprian FS; Jimbo S; Maina T; Prysliak T; Windeyer C; Perez-Casal J
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311234
[No Abstract] [Full Text] [Related]
68. Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis.
Wasén C; Erlandsson MC; Bossios A; Ekerljung L; Malmhäll C; Töyrä Silfverswärd S; Pullerits R; Lundbäck B; Bokarewa MI
Front Immunol; 2018; 9():1677. PubMed ID: 30140263
[TBL] [Abstract][Full Text] [Related]
69. Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
Kushlinskii NE; Alferov AA; Boulytcheva IV; Timofeev YS; Korotkova EA; Khvan OT; Kuzmin YB; Kuznetsov IN; Bondarev AV; Shchupak MY; Sokolov NY; Efimova MM; Gershtein ES; Sushentsov EA; Aliev MD; Musaev ER
Klin Lab Diagn; 2020 Dec; 65(11):669-675. PubMed ID: 33301655
[TBL] [Abstract][Full Text] [Related]
70. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
Front Immunol; 2020; 11():613007. PubMed ID: 33488620
[TBL] [Abstract][Full Text] [Related]
71. High programmed death 1 expression on T cells in aplastic anemia.
Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
[TBL] [Abstract][Full Text] [Related]
72. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
73. Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
Feng X; Luo X; Yang Y; Fan Y; Ye Q
Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
[TBL] [Abstract][Full Text] [Related]
74. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
75. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
[TBL] [Abstract][Full Text] [Related]
76. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract][Full Text] [Related]
77. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
78. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
79. Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease.
Chen KY; Sun WL; Wu SM; Feng PH; Lin CF; Chen TT; Lu YH; Ho SC; Chen YH; Lee KY
Cells; 2024 May; 13(10):. PubMed ID: 38786101
[TBL] [Abstract][Full Text] [Related]
80. Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer.
Qu Y; Wang H; Liu H; Sun X; Li J; Yu H
Biomed Res Int; 2021; 2021():8811751. PubMed ID: 33987445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
